Hope in Every Breath: Navigating the Therapeutic Landscape of Cystic Fibrosis
- PMID: 37719614
- PMCID: PMC10504422
- DOI: 10.7759/cureus.43603
Hope in Every Breath: Navigating the Therapeutic Landscape of Cystic Fibrosis
Abstract
Cystic fibrosis (CF) has long posed a complex challenge to medical science. Still, the tides are turning with remarkable progress in prognosis and demographics, thanks to cutting-edge medical management and treatment breakthroughs. It affects multiple systems, necessitating a comprehensive approach to its management. This article thoroughly reviews the latest advancements in CF treatment across three key areas: respiratory care, infection prevention, and pharmacological management. In respiratory care, emphasis is placed on airway clearance therapies and nebulized saline, while infection prevention strategies encompass hand hygiene, respiratory etiquette, and environmental cleaning and disinfection. Pharmacological management explores pancreatic enzyme replacement therapy (PERT), antimicrobial treatments, cystic fibrosis transmembrane regulator (CFTR) modulators, and promising gene therapies. Patient education and support are highlighted as crucial components of effective CF management, while mental health assessments are emphasized due to CF patients' susceptibility to anxiety and depression. This review highlights the tremendous progress made in the management of CF. Integrating early detection, infection prevention, pharmacological interventions, gene therapy, and patient support is revolutionizing the care and quality of life for individuals with CF.
Keywords: cftr modulating therapy; chest physiotherapy; cystic fibrosis (cf); gene therapy; hand hygiene compliance; infection prevention and control; patient education; pulmonary screening; respiratory care.
Copyright © 2023, Sreenivasulu et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 36990700 Chinese.
-
Cystic Fibrosis Transmembrane Regulator Modulators: Implications for the Management of Depression and Anxiety in Cystic Fibrosis.Psychosomatics. 2017 Jul-Aug;58(4):343-354. doi: 10.1016/j.psym.2017.04.001. Epub 2017 Apr 5. Psychosomatics. 2017. PMID: 28576305 Review.
-
Airway clearance devices for cystic fibrosis: an evidence-based analysis.Ont Health Technol Assess Ser. 2009;9(26):1-50. Epub 2009 Nov 1. Ont Health Technol Assess Ser. 2009. PMID: 23074531 Free PMC article.
-
CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis.Front Pharmacol. 2016 Sep 5;7:275. doi: 10.3389/fphar.2016.00275. eCollection 2016. Front Pharmacol. 2016. PMID: 27656143 Free PMC article. Review.
-
Exploring Therapeutic Strategies for Pediatric Cystic Fibrosis: An In-Depth Comparative Review.Cureus. 2024 Oct 20;16(10):e71913. doi: 10.7759/cureus.71913. eCollection 2024 Oct. Cureus. 2024. PMID: 39564025 Free PMC article. Review.
Cited by
-
Macroenzymes as a reason for aminotransferases flare in cystic fibrosis patients on CFTR modulators therapy - Report of three cases.Heliyon. 2024 May 13;10(10):e31189. doi: 10.1016/j.heliyon.2024.e31189. eCollection 2024 May 30. Heliyon. 2024. PMID: 38813168 Free PMC article.
-
Cutting-Edge Advances in Cystic Fibrosis: From Gene Therapy to Personalized Medicine and Holistic Management.Genes (Basel). 2025 Mar 30;16(4):402. doi: 10.3390/genes16040402. Genes (Basel). 2025. PMID: 40282362 Free PMC article. Review.
-
Clinical Disorders in Cystic Fibrosis That Affect Emergency Procedures-A Case Report and Review.J Clin Med. 2025 May 5;14(9):3187. doi: 10.3390/jcm14093187. J Clin Med. 2025. PMID: 40364218 Free PMC article. Review.
-
Patients with cystic fibrosis do not have an increased risk of adverse events after endoscopic retrograde cholangiopancreatography: a propensity-matched analysis.Ann Gastroenterol. 2025 Jul-Aug;38(4):446-452. doi: 10.20524/aog.2025.0983. Epub 2025 Jun 30. Ann Gastroenterol. 2025. PMID: 40697435 Free PMC article.
References
-
- Cystic fibrosis: current concepts. López-Valdez JA, Aguilar-Alonso LA, Gándara-Quezada V, Ruiz-Rico GE, Ávila-Soledad JM, Reyes AA, Pedroza-Jiménez FD. https://doi.org/10.24875/BMHIM.20000372. Bol Med Hosp Infant Mex. 2021;78:584–596. - PubMed
-
- The changing epidemiology of cystic fibrosis: incidence, survival and impact of the CFTR gene discovery. Scotet V, L'Hostis C, Férec C. https://doi.org/10.3390/genes11060589. Genes. 2020;11:589. - PMC - PubMed
-
- Cystic fibrosis lung disease: an overview. Turcios NL. https://doi.org/10.4187/respcare.06697. Respir Care. 2020;65:233–251. - PubMed
-
- CFTR: cystic fibrosis and beyond. Mall MA, Hartl D. https://doi.org/10.1183/09031936.00228013. Eur Respir J. 2014;44:1042–1054. - PubMed
-
- Cystic fibrosis diagnosis and newborn screening. Rosenfeld M, Sontag MK, Ren CL. Pediatr Clin North Am. 2016;63:599–615. - PubMed
Publication types
LinkOut - more resources
Full Text Sources